Abstract
The complete genome sequence revealed a family of 32 outer membrane proteins (OMPs) in Helicobacter pylori. We examined the effect of four OMPs (HP0638, HP0796, HP1501, and babA2) on the production of the proinflammatory cytokine, IL-8. Mutants of the four OMPs, as well as cagE and galE from H. pylori from the U.S. and Japan, were constructed by inserting a chloramphenicol-resistant cassette into the gene. Twenty-two pairs of parental and mutant H. pylori strains, as well as 160 clinical isolates (80 from Japanese and 80 from U.S.), were cocultured with gastric cancer cell lines. IL-8 production in the supernatant and adhesion was assayed by ELISA. HP0796, HP1501, babA2, and galE gene knockouts had no significant effect on IL-8 production. Knockout of the HP0638 gene in 81% of cag-positive strains reduced IL-8 production approximately 50%. The three cag-positive strains in which IL-8 levels were unchanged by HP0638 knockout had five or seven CT dinucleotide repeats in the 5′ region, resulting in a frame shift and truncation. Strains with naturally inactive HP0638 gene were all from the U.S.; Japanese strains were always “on” and thus, on average, may be more virulent. Although cag-negative isolates produced a limited IL-8 response, cag-negative strains that contained a functional HP0638 gene produced more than 3-fold greater IL-8 than cag-negative nonfunctional HP0638 strains. We hypothesize that functional HP0638 gene may be an important virulence factor in relation to the risk of clinically significant outcomes of H. pylori infection. We denote HP0638 gene as outer inflammatory protein (oipA).
Helicobacter pylori-related gastritis is characterized by mucosal infiltration with neutrophils and mononuclear cells. The migration and activation of these cells into the gastric mucosa is thought to be related to the local production of various proinflammatory cytokines (1, 2), especially IL-8, a potent neutrophil chemotactic and activating peptide (3). Antral mucosal IL-8 levels are closely related to the H. pylori density (2), and H. pylori density, cellular infiltration, and mucosal IL-8 levels are significantly greater in duodenal (DU) ulcer than in simple gastritis, suggesting a role for IL-8 in H. pylori inflammation and H. pylori-associated gastroduodenal diseases (2).
Studies regarding the relationship between H. pylori and IL-8 have primarily focused on the cag pathogenicity island (PAI) (1, 2, 4–6). The presence of a functional cag PAI is associated with increased IL-8 production, and many of the genes contained within this island, such as cagE, may affect the inflammatory response (6). However, there are also data to suggest that the cag PAI is not the sole H. pylori factor able to promote IL-8 secretion. We, and others, have found that some cag-negative strains produced IL-8 from cell lines such as MKN45, AGS, and KATO III (2, 4, 5). In addition, although IL-8 levels are typically low in gastric biopsy specimens from patients with cag-negative H. pylori infections, mucosal IL-8 levels in some cag-negative cases are higher than the median IL-8 values of cag-positive cases and showed severe cellular infiltration (2). Together, these observations suggest the presence of a virulence factor(s) other than the cag PAI involved in IL-8 production.
In vitro experiments indicate that IL-8 is produced from the epithelial cells after viable H. pylori attached to the cells (5). Thus, whereas direct interaction and possibly translocation of factors are known to be important (7), the outer membrane proteins (OMPs) are good candidates for the unknown proinflammatory virulence factor(s). Thirty-two genes encoding OMPs were identified after computer inspection of two complete genome sequences of H. pylori (8, 9).
We recently reported that the IL-8 levels in the corporal mucosa were related to the presence of serum Ab against a Mr 33,000 to 35,000 Ag (10). Only two gene products, HP0638 (Mr 34,000) and HP0796 (Mr 33,000), were within that range of molecular weight among the OMP family (HP number from ref. 8). We had previously studied a Mr 32,000 Ag from Mycobacterium paratuberculosis, which had binding properties to fibronectin and may be an adherence factor (11). Using primers specific for this Ag, the same size fragment was amplified from H. pylori DNA. Sequence analysis indicated that this fragment was from an OMP (HP1501).
In this study, we examined the roles of four OMPs (HP0638, HP0796, HP1501, and BabA) in IL-8 induction. We chose BabA as it has been described as an OMP that appears to be involved in adherence of H. pylori to Lewis-b (Leb) blood group Ags on gastric epithelial cells (12). Functional BabA is encoded by the babA2 gene. The babA2 gene is identical to the babA1 gene with the exception of an insert of 10 bp with a repeat motif in the signal peptide sequence, which results in the creation of a translational initiation codon and has Leb binding ability. We also examined the galE gene, which is involved in lipopolysaccharide biosynthesis of H. pylori (13) as a control and as a candidate to induce IL-8. Here we show that the functional HP0638 gene may be an important virulence factor in relation to the risk of clinically significant outcomes of H. pylori infection. We designated HP0638 gene as outer inflammatory protein (oipA) gene of H. pylori.
Materials and Methods
H. pylori Studied.
H. pylori were obtained from 80 Japanese patients (56 men and 24 women; mean age 52 years) from Kyoto Prefectural University of Medicine (Kyoto, Japan) and 80 U.S. patients (67 men and 13 women; mean age 52 years) from Veterans Affairs Medical Center (Houston, TX) (40 with DU, and 40 with gastritis in both countries). DU was identified endoscopically, and gastritis was defined as histologic gastritis with no peptic ulcer, gastric cancer, or esophageal disease. Biopsies were obtained with informed consent from all patients under protocols approved by each local ethics committee.
In addition, H. pylori 26695 (ATCC 700392) (American Type Culture Collection, Manassas, VA) and Sydney strain (SS1) (a gift from A. Lee, University of New South Wales, Sydney, Australia) were used as reference H. pylori strains.
H. pylori Genotyping.
Antral biopsy specimens were obtained for isolation of H. pylori, as previously described (14). Multiple colonies were collected together, and all stock cultures were maintained at −80°C in Brucella broth supplemented with 20% glycerol. Clinical isolates underwent a maximum of seven in vitro passages before incubation with the gastric epithelial cells. The two reference strains (26695 and SS1) had been passaged multiple times without documentation of the exact number of passages. Genomic DNA from H. pylori was extracted by using the QIAamp Tissue kit (Qiagen, Chatsworth, CA).
cag PAI status was evaluated by PCR for the combination of cagA, cagE, and cagG and by immunoblot analysis for CagA protein by using recombinant CagA polyclonal Ab (Oravax, Cambridge MA), as previously described (2). The vacA genotype (s and m region), iceA allele (iceA1 or iceA2), and babA2 status (babA2-positive or -negative) were evaluated by PCR, as previously described (14, 15).
Construction of Isogenic Mutant Strains of H. pylori.
For construction of isogenic mutant strains, we collected a single colony from stock frozen H. pylori that had been collected from multiple colonies. A portion of the genes encoding HP0638, HP0796, HP1501, babA2, and cagE gene were amplified by PCR, and the amplified-fragment was inserted into the EcoRV restriction enzyme site of pBluescriptSK+ (Stratagene). A chloramphenicol resistance gene cassette (cat) (a gift from D. E. Taylor, University of Alberta, Edmonton, Canada) was inserted into SspI, Eco47III, AccI, BglII, and Eco47III sites of the insert DNA for HP0638, HP0796, HP1501, babA2, and cagE, respectively. A kanamycin resistance gene cassette (km) (a gift from R. Haas, Max von Pettenkofer Institut, Munich, Germany) was also inserted into the Eco47III site of insert DNA for cagE, and the resulting plasmid was used for dual inactivation by selecting on a chloramphenicol and kanamycin plate. All of the plasmids (1 to 2 μg) were used for inactivation of chromosomal genes by natural transformation as previously described (16). Inactivation of the genes was confirmed by PCR amplification followed by Southern blot hybridization. Isogenic galE mutant was constructed as previously described (13).
IL-8 Levels from Gastric Cancer Cells Cocultured with H. pylori.
In vitro IL-8 measurement was performed as previously described (2). Briefly, MKN45 cells (1 × 105/well), AGS cells (5 × 104/well), and KATO III cells (1 × 105/well) were plated into 24-well plates and cultured for 2 days (about 5 × 105/ml for each cells). Stock frozen H. pylori was cultured in brain–heart infusion broth containing 5% horse serum with a rotatory shaker for 24 to 48 h, representing growth phases. Isogenic mutants of each gene were used for incubation with the same in vitro passage level as parental strains. H. pylori was added to the cultured cells (bacterium-to-cell ratio of 100:1) and incubated for 24 h. IL-8 in the supernatant was assayed by ELISA (R&D Systems) in duplicate for experiments that used only wild-type strains or in triplicate for experiments that used parental and knockout mutants.
Sequences Analysis of the HP0638 Gene.
According to the complete genome sequence of H. pylori, dinucleotide repeats were located in the region encoding the signal sequences of HP0638 (8, 9). The signal sequences of HP0638 including the repeats were amplified by PCR using primer pairs 5′-CAAGCGCTTAACAGATAGGC-3′ (forward) and 5′-GCTTCACGAGAAAACGCCTT-3′ (reverse). Amplified DNA fragments were subcloned into the pBluescriptSK+ (Stratagene), and the DNA sequence determination was performed at the Molecular Genetics Facility at Baylor College of Medicine.
Quantification of H. pylori Adhesion to Gastric Cancer Cells.
Quantitative evaluation of H. pylori adhesion to AGS cells was performed by ELISA as previously described (17, 18). Briefly, AGS cells (5 × 104/well) were plated into 96-well plates and cultured for 2 days (about 5 × 105/well). H. pylori (the culture conditions were identical to those in the experiments for IL-8 measurement) was added to the cultured cells (bacterium-to-cell ratio of 500:1) and incubated for 90 min. After washing, adherent H. pylori and cells were fixed at 4°C for 60 min by using 8% paraformaldehyde. Anti-H. pylori Ab (diluted 1:50) (Dako) was used for the first Ab and peroxidase-conjugated goat anti-rabbit immunoglobulins (diluted 1:1000) (Sigma) for the second Ab; o-phenylenediamine (0.4 mg/mg) (Sigma) was the substrate. The reaction was terminated by 3 M H2SO4, and the OD at 490 nm was used as the index of the number of H. pylori adhering to AGS cells (17).
Data Analysis.
Statistical analysis was performed by Mann–Whitney Rank Sum test, paired t, and Spearman rank test depending on the data set of concern. A P value of less than 0.05 was accepted as statistically significant.
Results
IL-8 Production from Gastric Cancer Cells Cocultured with Wild-Type H. pylori.
H. pylori had the ability to induce IL-8 from all three cancer cell lines (Fig. 1). Although IL-8 secretion differed according to the cell lines used, the IL-8 levels were significantly related among the cancer cells (AGS vs. MKN45; r = 0.91, AGS vs. KATO III; r = 0.89, MKN45 vs. KATO III, r = 0.89; P < 0.0001 for each). Therefore, we present detailed data using AGS cells.
There was no relationship between IL-8 levels and the iceA allele either from U.S. or Japanese strains (U.S., 2309 and 2549 pg/ml; Japanese, 3523 and 3222 pg/ml; iceA1 and iceA2, respectively). High IL-8 production was observed in cag-positive strains irrespective of whether vacA s or m subtype or babA2 status (the mean IL-8 levels in vacA s2, vacA m2, and babA2-negative were 3362, 3175, and 3325 pg/ml, respectively) compared with 3231, 3238, and 3228 pg/ml for vacA s1, vacA m1, and babA2-positive strains, respectively. In addition, low IL-8 production was observed in cag-negative strains irrespective of vacA s or m subtype or babA2 status (the mean IL-8 level in vacA s1, vacA m1, or babA2-positive strains was 158, 394, and 135 pg/ml, respectively). Together, these findings are consistent with the notion that IL-8 production is most dependent on a functional cag secretion system and less on vacA or babA status.
Even among cag-positive isolates, IL-8 levels differed greatly, especially among the U.S. isolates (Fig. 1). IL-8 levels among the cag-positive Japanese isolates were more homogenous and significantly greater than with cag-positive U.S. isolates (Japanese, 3566 pg/ml; U.S., 2862 pg/ml; P < 0.0001). In the U.S. cag-positive isolates, IL-8 levels were significantly higher in DU cases compared with isolates from gastritis (DU, 3052 pg/ml; gastritis, 2662 pg/ml; P < 0.05). There was no difference in IL-8 levels among Japanese isolates irrespective of clinical presentation.
Adherence to Gastric Cancer Cells with Wild-Type Clinical Strains.
There was no relationship between adherence and cag PAI (Fig. 2A), babA2, iceA, or vacA genotypes (data not shown). Among cag-positive isolates, there was a significant relationship between adherence and IL-8 production from the AGS cells (Japanese strains, r = 0.83; U.S. strains, r = 0.48; P < 0.0001 for each) (Fig. 2A). The U.S. cag-positive isolates could be clearly divided into two groups. One overlapped the Japanese isolates; the other showed a positive correlation but with lower IL-8 production, suggesting that a mechanism other than adherence might be involved in IL-8 induction.
Generation of Isogenic Mutant Strains of H. pylori.
To evaluate the natural competence and transformation ability of H. pylori strains, we selected 40 clinical isolates (20 Japanese isolates and 20 U.S. isolates), as well as H. pylori 26695 and SS1. As a control gene for checking natural transformation, we chose the galE gene as it is not essential for H. pylori survival (13). Twenty-two strains (9 Japanese isolates, 11 U.S. isolates, 26695, and SS1) were transformable and were used for constructing gene negative mutants for HP0638, HP0796, HP1501, babA2, and cagE gene (Table 1).
Table 1.
Strain | Country | Disease | cagPAI | vacA | iceA | babA2 |
---|---|---|---|---|---|---|
26695 | U.K. | Gastritis | + | s1b-m1 | 1 | −∗ |
SS1 | Australia | Gastritis | + | s2-m2 | 2 | − |
JK43, JK44, JK46, JK51 | Japan | Gastritis | + | s1c-m1 | 1 | + |
JK23, JK91 | Japan | DU | + | s1c-m1 | 1 | + |
JK25 | Japan | DU | + | s1c-m1 | 2 | − |
JK35 | Japan | DU | + | s1c-m1 | 2 | + |
GI2060, GI2777 | U.S. | Gastritis | + | s1b-m1 | 2 | + |
GI2895 | U.S. | Gastritis | + | s1a-m1 | 1 | + |
GI2975 | U.S. | Gastritis | + | s1b-m1 | 1 | + |
GI2450 | U.S. | DU | + | s1b-m2 | 2 | + |
GI2826 | U.S. | DU | + | s1a-m2 | 2 | + |
JK2-41 | Japan | Gastritis | − | s1c-m1 | 2 | + |
GI2853 | U.S. | Gastritis | − | s2-m2 | 2 | + |
GI2924 | U.S. | Gastritis | − | s2-m2 | 2 | − |
GI3009 | U.S. | Gastritis | − | s2-m2 | 1 | − |
GI2490, GI2685 | U.S. | DU | − | s2-m2 | 2 | − |
H. pylori 26695 had reported as babA1 genotype because this has no ability to bind to Lewis b Ag. However, 26695 was classified as babA2 by our PCR techniques because sequence analysis of this strain showed that there was a 10-bp repeat motif in babA gene (HP1243).
Effect of Isogenic Mutant Strains for IL-8 Production and Adherence to Cells.
There was no difference in the ability to promote IL-8 secretion between the wild-type and isogenic HP1501, babA2, and galE mutants (data not shown). The HP0796 knockout mutant showed a minor reduction of IL-8 (mean 13% reduction). In contrast, HP0638 and cagE knockout mutants showed a major reduction in IL-8 production (mean 40% reduction) (Fig. 3). We designated HP0638 gene as outer inflammatory protein (oipA) of H. pylori because IL-8 has a major inflammatory effect in the gastric mucosa.
There were two types of oipA knockout mutants of cag-positive isolates in relation to IL-8 induction (Figs. 2B and 3A). In 13 of 16 cag-positive strains (all 8 Japanese, 3 of 6 U.S., 26695, and SS1), IL-8 production was significantly reduced with the oipA knockout mutants (mean 49% reduction), which we designated as putative functional oipA. In contrast, oipA knockout had no effect on IL-8 production in 3 U.S. strains (putative nonfunctional oipA).
IL-8 production was low in cag-negative parental strains; however, even in cag-negative isolates, a different effect of oipA knockout was seen between the putative functional and nonfunctional types (Fig. 3B) because IL-8 production was significantly reduced (mean 53%) in the putative functional oipA knockout mutants compared with their parental strains. The parental cag-negative strains with a putative functional oipA gene produced more than three times the amount of IL-8 compared with cag-negative isolates with a nonfunctional oipA gene.
As has previously been reported (4–6), IL-8 production from gastric cancer cells cocultured with the cagE knockout mutant was significantly reduced (mean 87% reduction) (Fig. 3A). The strains could be divided into two groups in relation to the oipA knockout mutants. Knockout of cagE of strains in which IL-8 levels were unchanged by oipA knockout had almost complete inhibition of IL-8 induction. In contrast, knockout of cagE in strains in which IL-8 levels were decreased by oipA knockout had only partial reduction in IL-8 production. We therefore constructed double knockout mutants of oipA and cagE gene from strains with a putative functional oipA, JK91, and GI2777, and from GI2060, which has a putative nonfunctional oipA. Double knockout of oipA and cagE reduced IL-8 production almost to control levels in strains with a putative functional oipA (90% and 92% reduction, JK91 and G2777, respectively) (Fig. 3A) and had no additional effect in strains with a nonfunctional oipA (cagE∷cat 96%, and oipA∷cat/cagE∷km 95% reduction). These findings are consistent with the notion that a putative functional oipA had a role in IL-8 induction. Knockout mutants of oipA, HP0796, HP1501, babA2, cagE, or galE had no effect on the adherence to AGS cells (data not shown).
Sequence Analysis in the Signal-Peptide Coding Region of the oipA Gene.
Strains with a putative nonfunctional oipA gene contained five and seven CT dinucleotide repeats in the signal-peptide coding region of the oipA gene that kept the peptide out-of-frame and the status was “off” (Table 2). In contrast, the U.S. strains that had putative functional oipA gene contained six and nine CT dinucleotide repeats that kept the peptide in frame and the status was “on,” suggesting that the slipped-strand repair mechanism modulates this gene. All Japanese isolates had only unmatured CT dinucleotide repeats, and the status was always “on”.
Table 2.
Interestingly, all isolates with nonfunctional oipA gene (status “off”) were among those with relatively low IL-8 production compared with adhesion (Fig. 2B). In contrast, all but one clinical isolate with a functional oipA gene (status “on”) had relatively high IL-8 production compared with adhesion.
Effect of Multiple Laboratory Passage in Wild-Type Strains.
The maximum passage number of the H. pylori isolates used was seven (except for 26695 and SS1). To examine the effect of in vitro passage, IL-8 production from cancer cells cocultured with H. pylori with different passage numbers [initial passage (3 to 5), 20, and 30 passages] was measured by using five clinical isolates (three U.S. and two Japanese strains) obtained from a single colony. IL-8 levels were decreased dramatically after 30 passages in one U.S. isolate (mean ± SD, initially 3620 ± 346; and after 30 passages, 1543 ± 254 pg/ml; P < 0.0001). Sequence analysis showed that the number of CT dinucleotide repeats in the oipA gene had changed from six (status “on”) (initial) to five (status “off”) (30 passages). In four other clinical isolates, IL-8 levels decreased slightly after 30 passages (initially 3457 ± 487; and after 30 passages, 3050 ± 367 pg/ml; P < 0.05). There were no changes in the number of CT dinucleotide repeats in the oipA gene in these four isolates, indicating that some unknown factors induced by multiple passages may be involved in inhibition of IL-8 in vitro. Adherence to AGS cells was not changed by multiple passage in all five strains (data not shown).
Discussion
We found that not only cag PAI but also the oipA gene has the ability to induce IL-8 from gastric epithelial cells. Three other members of the OMP family, babA, HP0796, and HP1501, had no significant effect on IL-8 production. H. pylori could be divided into two types (functional and nonfunctional) in relation to the oipA gene, based on their ability to induce IL-8. Inactivation of the functional oipA gene caused an approximately 50% reduction in IL-8 production. Inactivation of the cagE gene caused a dramatic reduction in IL-8 production; IL-8 secretion remained significantly above control values if the parental strain had a functional oipA gene. Double knockout of the cagE and oipA genes almost completely eliminated IL-8 production. Spontaneous natural inactivation of the oipA gene that occurred during multiple passage in vitro was also associated with a marked reduction of IL-8 production. Together, these findings suggest that a functional oipA gene plays an important role in IL-8 induction.
We also showed that the oipA gene is regulated by slipped-strand repair mechanism. Based on the complete genome sequence of H. pylori, five members of the OMP family contain CT dinucleotide repeats in their signal-sequence coding regions (8, 9). Recently, another member of the OMP family, hopZ gene, whose product was related to adherence, was also reported to be regulated by the slipped-strand repair mechanism (19). Together, these findings support the hypothesis that slipped-strand repair mechanisms have evolved in bacterial pathogens to increase the frequency of phenotypic variation in genes involved in critical interactions with their hosts (8, 9).
Japanese clinical isolates had greater ability to induce IL-8 compared with the U.S. isolates, and this ability was associated with the fact that there were only unmatured CT dinucleotide repeats in the oipA gene in the Japanese isolates, such that the status was always “on.” The difference in the ability to induce IL-8 among Japanese and U.S. isolates disappeared when we compared only isolates with a functional oipA gene. It is tempting to speculate that the different prevalence in gastroduodenal diseases between Japan and the U.S. may be, in part, related to the difference in the prevalence of H. pylori with a functional oipA gene. In vitro IL-8 levels were significantly higher in DU isolates in the U.S. compared with gastritis isolates. There may be relationship in the different prevalence of functional oipA gene between DU and gastritis.
The exact mechanism of H. pylori-associated IL-8 production from the epithelial cells has not been established. It is now recognized that CagA is translocated into the host cell by the type IV secretion system and becomes tyrosine-phosphorylated (20–23). However, the cagA gene knockout mutant does not affect IL-8 production in vitro (4–6). Several investigators studying the signal transduction pathway related to H. pylori-associated IL-8 induction have noted that H. pylori differ in their ability to promote IL-8 secretion (4–6). These differences may have reflected undetected differences in the oipA gene. Further study will be necessary to investigate the relationship between the oipA gene and H. pylori-associated induction of IL-8 secretion.
With a few exceptions, IL-8 production in vitro requires the presence of attachment of viable H. pylori to the epithelial cells (5). Although neither oipA nor cagE knockout had an effect on adherence, we found a positive correlation between adherence and IL-8 levels in strains with a functional as well as a nonfunctional oipA gene, suggesting that, although adherence is required, the oipA gene products role in IL-8 induction is related to a mechanism that is independent of adherence. H. pylori are reported to use at least five different adhesins to attach to gastric epithelial cells (8), suggesting that knockout mutants of only one of these genes may not reduce adherence to gastric cells and that multiple number of OMP families may cooperate in adhering to the epithelial cells.
We initially selected HP0638 (oipA) (Mr 34,000) and HP0796 (Mr 33,000) because of our observation that IL-8 levels in biopsies of the gastric corpus in Japanese patients were related to the presence of serum Ab against a Mr 33,000 to 35,000 Ag (10). However, all of the Japanese strains had a functional oipA gene, suggesting that the Mr 33,000 to 35,000 Ag noted in our previous study may be different from the oipA gene.
Acknowledgments
We thank Dr. Adrian Lee for providing Sydney strain (SS1), Dr. Rainer Haas for providing H. pylori/E. coli shuttle vectors, Dr. Diane E. Taylor for providing chloramphenicol resistance gene cassette, and Oravax, Inc., for providing recombinant CagA polyclonal Ab. This work was supported in part by the Department of Veterans Affairs and by National Institutes of Health Grant DK53659, as well as by the generous support of Hilda Schwartz.
Abbreviations
- OMP
outer membrane protein
- PAI
pathogenicity island
- DU
duodenal ulcer
- oipA
outer inflammatory protein
Footnotes
This paper was submitted directly (Track II) to the PNAS office.
Data deposition: The DNA sequences reported in this paper have been deposited in the GenBank database (accession nos. AF233660–AF233683).
Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073/pnas.130079797.
Article and publication date are at www.pnas.org/cgi/doi/10.1073/pnas.130079797
References
- 1.Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Gastroenterology. 1996;110:1744–1752. doi: 10.1053/gast.1996.v110.pm8964399. [DOI] [PubMed] [Google Scholar]
- 2.Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham D Y. Gut. 1999;45:804–811. doi: 10.1136/gut.45.6.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Matsushima K, Oppenheim J J. Cytokine. 1989;1:2–13. doi: 10.1016/1043-4666(89)91043-0. [DOI] [PubMed] [Google Scholar]
- 4.Crabtree J E, Covacci A, Farmery S M, Xiang Z, Tompkins D S, Perry S, Lindley I J, Rappuoli R. J Clin Pathol. 1995;48:41–45. doi: 10.1136/jcp.48.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Sharma S A, Tummuru M K, Miller G G, Blaser M J. Infect Immun. 1995;63:1681–1687. doi: 10.1128/iai.63.5.1681-1687.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Censini S, Lange C, Xiang Z, Crabtree J E, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. Proc Natl Acad Sci USA. 1996;93:14648–14653. doi: 10.1073/pnas.93.25.14648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Covacci A, Telford J L, Del Giudice G, Parsonnet J, Rappuoli R. Science. 1999;284:1328–1333. doi: 10.1126/science.284.5418.1328. [DOI] [PubMed] [Google Scholar]
- 8.Tomb J F, White O, Kerlavage A R, Clayton R A, Sutton G G, Fleischmann R D, Ketchum K A, Klenk H P, Gill S, Dougherty B A, et al. Nature (London) 1997;388:539–547. doi: 10.1038/41483. [DOI] [PubMed] [Google Scholar]
- 9.Alm R A, Ling L L, Moir D T, King B L, Brown E D, Doig P C, Smith D R, Noonan B, Guild B C, deJonge B L, et al. Nature (London) 1999;397:176–180. doi: 10.1038/16495. [DOI] [PubMed] [Google Scholar]
- 10.Yamaoka Y, Kodama T, Graham D Y, Kashima K. Dig Dis Sci. 1998;43:1482–1487. doi: 10.1023/a:1018850412148. [DOI] [PubMed] [Google Scholar]
- 11.El-Zaatari F A K, Naser S A, Engstrand L, Hachem C Y, Graham D Y. Curr Microbiol. 1994;29:177–184. doi: 10.1007/BF01570760. [DOI] [PubMed] [Google Scholar]
- 12.Ilver D, Arnquist A, Ögren J, Frick I, Kersulyte D, Incecik E T, Berg D, Covacci A, Engstrand L, Borén T. Science. 1998;279:373–377. doi: 10.1126/science.279.5349.373. [DOI] [PubMed] [Google Scholar]
- 13.Kwon D H, Woo J S, Perng C L, Go M F, Graham D Y, El-Zaatari F A K. Curr Microbiol. 1998;37:144–148. doi: 10.1007/s002849900354. [DOI] [PubMed] [Google Scholar]
- 14.Yamaoka Y, Kodama T, Gutierrez O, Kim J G, Kashima K, Graham D Y. J Clin Microbiol. 1999;37:2274–2279. doi: 10.1128/jcm.37.7.2274-2279.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gerhard M, Lehn N, Neumayer N, Borén T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Proc Natl Acad Sci USA. 1999;96:12778–12783. doi: 10.1073/pnas.96.22.12778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Heuermann D, Haas R. Mol Gen Genet. 1998;257:519–528. doi: 10.1007/s004380050677. [DOI] [PubMed] [Google Scholar]
- 17.Hayashi S, Sugiyama T, Yachi A, Yokota K, Hirai Y, Oguma K, Fujii N. J Gastroenterol Hepatol. 1997;12:373–375. doi: 10.1111/j.1440-1746.1997.tb00445.x. [DOI] [PubMed] [Google Scholar]
- 18.Hayashi S, Sugiyama T, Amano K, Isogai H, Isogai E, Aihara M, Kikuchi M, Asaka M, Yokota K, Oguma K, et al. Antimicrob Agents Chemother. 1998;42:1895–1899. doi: 10.1128/aac.42.8.1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Peck B, Ortkamp M, Diehl K D, Hundt E, Knapp B. Nucleic Acids Res. 1999;27:3325–3333. doi: 10.1093/nar/27.16.3325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Segal E D, Cha J, Lo J, Falkow S, Tompkins L S. Proc Natl Acad Sci USA. 1999;96:14559–14564. doi: 10.1073/pnas.96.25.14559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Stein M, Rappuoli R, Covacci A. Proc Natl Acad Sci USA. 2000;97:1263–1268. doi: 10.1073/pnas.97.3.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y, Tsubokawa M, Tohyama Y, Maeda S, Omata M, et al. J Exp Med. 2000;191:593–602. doi: 10.1084/jem.191.4.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Science. 2000;287:1497–1500. doi: 10.1126/science.287.5457.1497. [DOI] [PubMed] [Google Scholar]